0 0 0 0 0.00578034682080915 0.00578034682080915 0.00578034682080915 0.00578034682080915
Sign Up Today X
Thanks for submitting the form.
Stockreport

J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Through a voluntary agreement with the Trump administration, J&J will now offer unspecified medicines from its portfolio at lower prices to cash-paying patients through the government-run, direct-to-consumer (DTC) platform, TrumpRx.gov. In exchange for slashing its rates on medicines, the New Jersey pharma will gain immunity to the 100% tariffs on imported branded pharmaceuticals threatened by Trump back in April 2025. J&J's deal comes amid a swathe of agreements between pharma companies and the Trump administration, with nine deals involving Genentech, Gilead Sciences, GSK, MSD, Amgen, Bristol Myers Squibb (BMS), Boehringer Ingelheim, Novartis and Sanofi announced in December 2025. Pfizer and AstraZeneca were the first to come to a drug pricing agreement with the White House, with both companies striking deals in October 2025. These agreements were set in stone after Trump called on 17 large pharma companies to cut drug prices on the US market. Of these 17, AbbVie and Regene [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Through a voluntary agreement with the Trump administration, J&J will now offer unspecified medicines from its portfolio at lower prices to cash-paying patients through the government-run, direct-to-consumer (DTC) platform, TrumpRx.gov. In exchange for slashing its rates on medicines, the New Jersey pharma will gain immunity to the 100% tariffs on imported branded pharmaceuticals threatened by Trump back in April 2025. J&J's deal comes amid a swathe of agreements between pharma companies and the Trump administration, with nine deals involving Genentech, Gilead Sciences, GSK, MSD, Amgen, Bristol Myers Squibb (BMS), Boehringer Ingelheim, Novartis and Sanofi announced in December 2025. Pfizer and AstraZeneca were the first to come to a drug pricing agreement with the White House, with both companies striking deals in October 2025. These agreements were set in stone after Trump called on 17 large pharma companies to cut drug prices on the US market. Of these 17, AbbVie and Regene [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS